BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 29975360)

  • 41. Measurement of negative and depressive symptoms: Discriminatory relevance of affect and expression.
    Richter J; Hölz L; Hesse K; Wildgruber D; Klingberg S
    Eur Psychiatry; 2019 Jan; 55():23-28. PubMed ID: 30384108
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A large European, multicenter, multinational validation study of the Brief Negative Symptom Scale.
    Mucci A; Vignapiano A; Bitter I; Austin SF; Delouche C; Dollfus S; Erfurth A; Fleischhacker WW; Giordano GM; Gladyshev I; Glenthøj B; Gütter K; Hofer A; Hubeňák J; Kaiser S; Libiger J; Melle I; Nielsen MØ; Papsuev O; Rybakowski JK; Sachs G; Üçok A; Wojciak P; Galderisi S
    Eur Neuropsychopharmacol; 2019 Aug; 29(8):947-959. PubMed ID: 31255394
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Significance of primary negative symptoms in schizophrenic and other psychiatric patients].
    Gerbaldo H; Müller-Siecheneder F
    Fortschr Neurol Psychiatr; 1996 Jun; 64(6):221-7. PubMed ID: 8766995
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Next-generation negative symptom assessment for clinical trials: validation of the Brief Negative Symptom Scale.
    Strauss GP; Keller WR; Buchanan RW; Gold JM; Fischer BA; McMahon RP; Catalano LT; Culbreth AJ; Carpenter WT; Kirkpatrick B
    Schizophr Res; 2012 Dec; 142(1-3):88-92. PubMed ID: 23127378
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Alexithymia in negative symptom and non-negative symptom schizophrenia].
    Nkam I; Langlois-Thery S; Dollfus S; Petit M
    Encephale; 1997; 23(5):358-63. PubMed ID: 9453928
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Revisiting the persistent negative symptoms proxy score using the Clinical Assessment Interview for Negative Symptoms.
    Li Y; Li WX; Zou YM; Yang ZY; Xie DJ; Yang Y; Lui SSY; Strauss GP; Cheung EFC; Chan RCK
    Schizophr Res; 2018 Dec; 202():248-253. PubMed ID: 29996973
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The motivation and pleasure deficits but not expressivity affects social functioning through cognitive function in male patients with schizophrenia: A structural equation model.
    Cai R; Huang C; Ni L; Liu Z; Zhang S; Qiu Y; Hu J; Gao J; Yu M; Tang X; Zhou C; Zhang X; Zhang X; Fang X
    Asian J Psychiatr; 2023 Jul; 85():103616. PubMed ID: 37163944
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Concordance of self- and observer-rated motivation and pleasure in patients with negative symptoms and healthy controls.
    Engel M; Lincoln TM
    Psychiatry Res; 2017 Jan; 247():1-5. PubMed ID: 27863311
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Motivation and Pleasure Scale-Self-Report (MAP-SR): reliability and validity of a self-report measure of negative symptoms.
    Llerena K; Park SG; McCarthy JM; Couture SM; Bennett ME; Blanchard JJ
    Compr Psychiatry; 2013 Jul; 54(5):568-74. PubMed ID: 23351831
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multivariate predictors of social skills performance in middle-aged and older out-patients with schizophrenia spectrum disorders.
    Sitzer DI; Twamley EW; Patterson TL; Jeste DV
    Psychol Med; 2008 May; 38(5):755-63. PubMed ID: 17803830
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cross Cultural Validation and Extension of the Clinical Assessment Interview for Negative Symptoms (CAINS) in the Chinese Context: Evidence from a Spectrum Perspective.
    Xie DJ; Shi HS; Lui SSY; Shi C; Li Y; Ho KKY; Hung KSY; Li WX; Yi ZH; Cheung EFC; Kring AM; Chan RCK
    Schizophr Bull; 2018 Oct; 44(suppl_2):S547-S555. PubMed ID: 29471331
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Validation of a European Spanish-version of the Self-Evaluation of Negative Symptoms (SNS) in patients with schizophrenia.
    García-Álvarez L; Martínez-Cao C; Bobes-Bascarán T; Portilla A; Courtet P; de la Fuente-Tomás L; Velasco Á; González-Blanco L; Zurrón-Madera P; Fonseca-Pedrero E; Sáiz PA; García-Portilla MP; Bobes J
    Rev Psiquiatr Salud Ment (Engl Ed); 2022; 15(1):14-21. PubMed ID: 35256068
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The clinic of apathy in schizophrenia: a critical review of the issue].
    Yazbek H; Raffard S; Del-Monte J; Pupier F; Larue A; Boulenger JP; Gély-Nargeot MC; Capdevielle D
    Encephale; 2014 Jun; 40(3):231-9. PubMed ID: 23958346
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The interactive effects of negative symptoms and social role functioning on suicide ideation in individuals with schizophrenia.
    Jahn DR; Bennett ME; Park SG; Gur RE; Horan WP; Kring AM; Blanchard JJ
    Schizophr Res; 2016 Feb; 170(2-3):271-7. PubMed ID: 26746862
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Negative symptoms in schizophrenia, assessed by the brief negative symptom scale, self-evaluation of negative symptom scale, and social cognition: a gender effect.
    Wójciak P; Domowicz K; Andrzejewska M; Rybakowski JK
    Int J Psychiatry Clin Pract; 2021 Sep; 25(3):252-257. PubMed ID: 32862741
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The deficit syndrome in schizophrenic and nonschizophrenic patients: preliminary studies.
    Gerbaldo H; Philipp M
    Psychopathology; 1995; 28(1):55-63. PubMed ID: 7871122
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Negative symptoms: clinical and psychometric aspects].
    Adida M; Azorin JM; Belzeaux R; Fakra E
    Encephale; 2015 Dec; 41(6 Suppl 1):6S15-7. PubMed ID: 26776385
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Schedule for evaluation of the deficit syndrome in schizophrenia: Schedule for Deficit Syndrome (SDS) (Kirkpatrick et al.). Importance pertinence of the SDS. Introduction of the French version].
    Ribeyre JM; Dollfus S; Lesieur P; Ménard JF; Petit M
    Encephale; 1994; 20(4):413-9. PubMed ID: 7988405
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inverse association between negative symptoms and body mass index in chronic schizophrenia.
    Mezquida G; Savulich G; Garcia-Rizo C; Garcia-Portilla MP; Toll A; Garcia-Alvarez L; Bobes J; Mané A; Bernardo M; Fernandez-Egea E
    Schizophr Res; 2018 Feb; 192():69-74. PubMed ID: 28412089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.